The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...

AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and ...

Stocks like Indian Bank, Tata Motors, ITC, Puravankara, Federal Bank, Bajel Projects, TVS Motor Company, Biocon, Force Motors ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

Aumolertinib is a third generation EGFR tyrosine kinase inhibitors, approved for use in patients with advanced EGFR-mutant non-small cell lung cancer (NSCLC). Here, the authors report a phase 2 ...

"Most patients treated for small cell lung cancer experience rapid progression of disease and there is a high unmet need in the advanced setting," he added. "These interim results from the first ...

There are two main types of lung cancer: non-small cell lung cancer and small cell lung cancer. People with non-small cell lung cancer tend to have a better prognosis than people with small cell lung ...

Uecker was inducted into the Baseball Hall of Fame in 2003. He died on January 16 after battling small-cell lung cancer since 2023. Yarrow was a singer-songwriter who was a member of the iconic ...

2018;10(12):3877. Wei J, Xiang J, Hao Y, et al. Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective ...